Research Highlight | Published:


Efficacy of a PSMA-targeted nanoparticle

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.


    Original article

    1. Autio, K. A. et al. Safety and efficacy of BIND-014, a docetaxel nanoparticle targeting prostate-specific membrane antigen for patients with metastatic castration-resistant prostate cancer. JAMA Oncol. (2018)

    Download references

    Author information

    Correspondence to Conor A. Bradley.

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark